RecruitingNot ApplicableNCT06586151

Testing a Gender-inclusive HIV Prevention Program

Harnessing the Power of Technology to Develop a Population-based HIV Prevention Program for Trans Girls


Sponsor

Center for Innovative Public Health Research

Enrollment

200 participants

Start Date

Sep 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

If, over time, data suggest the intervention impacts HIV preventive behavior at the population level, it will be unique in that it can be quickly and cost effectively scaled up to impact thousands of trans girls and nonbinary youth assigned male at birth.


Eligibility

Sex: MALEMin Age: 14 YearsMax Age: 18 Years

Inclusion Criteria9

  • assigned male sex at birth and currently have a non-cisgender identity (e.g., transgender girl, non-binary, gender fluid, unsure);
  • aged 14-18 years and have not yet graduated high school;
  • English-speaking;
  • the sole user of a cell phone with an unlimited text messaging plan;
  • have access to the Internet to complete online surveys;
  • intend to have the same cell number for the next 6 months;
  • provide informed assent;
  • not have taken part in a previous #TranscendentHealth study activity or know someone who is in the study to increase the diversity of input from transgirls, and
  • agree to enroll over the phone with study staff.

Interventions

BEHAVIORALTranscendent Health

Gender-inclusive HIV prevention program: Text messaging-based program that lasts 5 months. Content includes information, motivation and behavioral skills about how to prevent HIV, as well as information about healthy and unhealthy romantic relationships, and navigating issues related to one\'s gender.

BEHAVIORALText Messaging with Information

Text messaging-based program that lasts 5 months. Content includes information about HIV prevention and aspects of a healthy adolescent lifestyle (e.g., self-esteem).


Locations(1)

Center for Innovative Public Health Research

San Clemente, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06586151


Related Trials